Cargando…

Enhancement of endothelial permeability by free fatty acid through lysosomal cathepsin B-mediated Nlrp3 inflammasome activation

Obesity is an important risk factor for exacerbating chronic diseases such as cardiovascular disease and cancer. High serum level of saturated free fatty acids such as palmitate is an important contributor for obesity-induced diseases. Here, we examined the contribution of inflammasome activation in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lei, Chen, Yang, Li, Xiang, Zhang, Youzhi, Gulbins, Erich, Zhang, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341975/ https://www.ncbi.nlm.nih.gov/pubmed/27689324 http://dx.doi.org/10.18632/oncotarget.12302

Ejemplares similares

Activation of Nlrp3 Inflammasomes Enhances Macrophage Lipid-Deposition and Migration: Implication of a Novel Role of Inflammasome in Atherogenesis
por: Li, Xiang, et al.
Publicado: (2014)

Lysosomal Cathepsin Release Is Required for NLRP3-Inflammasome Activation by Mycobacterium tuberculosis in Infected Macrophages
por: Amaral, Eduardo P., et al.
Publicado: (2018)

Humanin Ameliorates Free Fatty Acid-Induced Endothelial Inflammation by Suppressing the NLRP3 Inflammasome
por: Li, Wenfeng, et al.
Publicado: (2020)

Cathepsin B Is Required for NLRP3 Inflammasome Activation in Macrophages, Through NLRP3 Interaction
por: Chevriaux, Angélique, et al.
Publicado: (2020)

NLRP3 inflammasome in endothelial dysfunction
por: Bai, Baochen, et al.
Publicado: (2020)

Instigation of endothelial Nlrp3 inflammasome by adipokine visfatin promotes inter‐endothelial junction disruption: role of HMGB1
por: Chen, Yang, et al.
Publicado: (2015)

Trimethylamine N-Oxide (TMAO) Inducing Endothelial Injury: UPLC-MS/MS-Based Quantification and the Activation of Cathepsin B-Mediated NLRP3 Inflammasome
por: Lei, Dongyu, et al.
Publicado: (2023)

Inhibition of NLRP3 inflammasome activation by cell-permeable stapled peptides
por: Pal, Arumay, et al.
Publicado: (2019)

Fatty acid synthesis and NLRP3-inflammasome
por: Moon, Jong-Seok, et al.
Publicado: (2015)

Bafilomycin A1 enhances NLRP3 inflammasome activation in human monocytes independent of lysosomal acidification
por: Yu, Shi, et al.
Publicado: (2020)

Endothelial Acid Sphingomyelinase Promotes NLRP3 Inflammasome and Neointima Formation During Hypercholesterolemia
por: Yuan, Xinxu, et al.
Publicado: (2022)

Apilimod activates the NLRP3 inflammasome through lysosome-mediated mitochondrial damage
por: Hou, Yingting, et al.
Publicado: (2023)

Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation
por: Tang, Tao-Tao, et al.
Publicado: (2018)

Extracellular cathepsin Z signals through the α(5) integrin and augments NLRP3 inflammasome activation
por: Campden, Rhiannon I., et al.
Publicado: (2021)

Kakonein restores hyperglycemia‐induced macrophage digestion dysfunction through regulation of cathepsin B‐dependent NLRP3 inflammasome activation
por: Lian, Dawei, et al.
Publicado: (2022)

Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023)

Saturated fatty acid-crystals activate NLRP3 inflammasome
por: Karasawa, Tadayoshi, et al.
Publicado: (2019)

Rhubarb free anthraquinones improved mice nonalcoholic fatty liver disease by inhibiting NLRP3 inflammasome
por: Wu, Chao, et al.
Publicado: (2022)

Differential effects of short chain fatty acids on endothelial Nlrp3 inflammasome activation and neointima formation: Antioxidant action of butyrate
por: Yuan, Xinxu, et al.
Publicado: (2018)

Anthrax Lethal Toxin Induced Lysosomal Membrane Permeabilization and Cytosolic Cathepsin Release Is Nlrp1b/Nalp1b-Dependent
por: Averette, Kathleen M., et al.
Publicado: (2009)

Sinapine Thiocyanate Ameliorates Vascular Endothelial Dysfunction in Hypertension by Inhibiting Activation of the NLRP3 Inflammasome
por: Liu, Yang, et al.
Publicado: (2021)

Therapeutic potential of lysosomal cathepsins for neurodegenerative diseases
por: Prieto Huarcaya, Susy, et al.
Publicado: (2022)

Lysosomal regulation of extracellular vesicle excretion during D-ribose-induced NLRP3 inflammasome activation in podocytes
por: Hong, Jinni, et al.
Publicado: (2019)

Cathepsin L3 From Fasciola hepatica Induces NLRP3 Inflammasome Alternative Activation in Murine Dendritic Cells
por: Celias, Daiana Pamela, et al.
Publicado: (2019)

SARS-COV-2 viroporins activate the NLRP3-inflammasome by the mitochondrial permeability transition pore
por: Guarnieri, Joseph W., et al.
Publicado: (2023)

AdipoRon Alleviates Free Fatty Acid-Induced Myocardial Cell Injury Via Suppressing Nlrp3 Inflammasome Activation
por: Zhang, You-Zhi, et al.
Publicado: (2019)

The Role of NLRP3 Inflammasome Signaling on Arrhythmias in Diabetes
por: Zhang, Lei, et al.
Publicado: (2022)

Formaldehyde treatment of proteins enhances proteolytic degradation by the endo-lysosomal protease cathepsin S
por: Michiels, Thomas J. M., et al.
Publicado: (2020)

The NLRP3 inflammasome in macrophages is stimulated by cell‐free hemoglobin
por: Shaver, Ciara M., et al.
Publicado: (2020)

Ugonin U stimulates NLRP3 inflammasome activation and enhances inflammasome-mediated pathogen clearance
por: Chen, Chun-Yu, et al.
Publicado: (2016)

The role of NLRP3 inflammasome in hepatocellular carcinoma
por: Zhao, Huijie, et al.
Publicado: (2023)

Lysosomal chloride transporter CLH-6 protects lysosome membrane integrity via cathepsin activation
por: Zhang, Qianqian, et al.
Publicado: (2023)

Induction of NLRP3 Inflammasome Activation by Heme in Human Endothelial Cells
por: Erdei, Judit, et al.
Publicado: (2018)

NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis
por: Wan, Zhaofei, et al.
Publicado: (2019)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

The NLRP3 inflammasome: contributions to inflammation-related diseases
por: Chen, Ying, et al.
Publicado: (2023)

Lysosomal elastase and cathepsin G in beige mice. Neutrophils of beige (Chediak-Higashi) mice selectively lack lysosomal elastase and cathepsin G
Publicado: (1986)

Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
por: Zhang, Tan, et al.
Publicado: (2021)

The Role of NLRP3 Inflammasome in IgA Nephropathy
por: Wu, Xiaofang, et al.
Publicado: (2022)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
por: Kim, Yang Gyun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mf92pgvb8ti3gqdjm00aqe9nqh